Erik Harris, Executive Vice President and Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. discusses what he has learned being a commercial officer for a rare disease pharmaceutical company.
Mr. Harris first notes the uniqueness of each patient’s story and the strength and courage he sees in all of them. This connection to patients is at the core of the company, which reminds him of why it is so important to keep patients in focus while the company works to build a commercial infrastructure. This not only grounds the company but allows them to navigate patients through finding and affording treatment.
To keep up to date on the latest developments in rare disease treatment, sign up for our weekly newsletter.